2014-02-05 14:48:28 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Japan Tissue Engineering Co., Ltd. (7774) and produced a report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal - SADIF Investment Analytics, announces a new summary due diligence report covering Japan Tissue Engineering Co., Ltd. (7774). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Japan Tissue Engineering Co., Ltd. investor.
Report Summary: Japan Tissue Engineering Co., Ltd. is a below average quality company with a neutral outlook. Japan Tissue Engineering Co., Ltd. has strong business growth and is run by inefficient management. The trend in Japan Tissue Engineering Co., Ltd. fair value exchange rate against its closest rated-competitor, NanoCarrier Co., Ltd., has been appreciating over the past 2 weeks. When compared to its closest competitor, Japan Tissue Engineering Co., Ltd. shows similar undervaluation and is equally likely
to underperform the market.
The report breaks down the Total StockMark into its three components - business, management and price, performing an in-depth analysis of Japan Tissue Engineering Co., Ltd. for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext and from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, One source West Services, and Dow Jones/Factiva.
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering 31 different markets and over 22,000 companies. The StockMarks rating system is based on proven investment principles and is designed to drive long-term shareholder returns.